APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Felbamate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Felbamate Market Outlook and Growth Opportunities 2026

Report ID 173991160420 December 2025195 pages

Choose your research edition.

Industry ResearchFelbamate Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Felbamate Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Felbamate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felbamate Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Felbamate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Felbamate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Felbamate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Felbamate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felbamate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Felbamate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Felbamate market include Sun Pharma, Mylan, Schering Plough, Merck Sharp and Dohme, Corepharma, Cadila Healthcare, ANI Pharmaceuticals, Amneal Pharmaceuticals and Alvogen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Felbamate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Felbamate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Felbamate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Felbamate market size, projected growth trends, production technologies, key applications, and end-use industries.

Felbamate Segment by Company

Sun Pharma

Mylan

Schering Plough

Merck Sharp and Dohme

Corepharma

Cadila Healthcare

ANI Pharmaceuticals

Amneal Pharmaceuticals

Alvogen

Felbamate Segment by Type

Tablet

Oral Solution

Felbamate Segment by Application

Refractory Lennox-Gastaut Syndrome

Refractory Seizure Disorders

Others

Felbamate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Felbamate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Felbamate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Felbamate significant trends, drivers, influence factors in global and regions.

6. To analyze Felbamate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felbamate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felbamate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felbamate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Felbamate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Felbamate industry.

Chapter 3: Detailed analysis of Felbamate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Felbamate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Felbamate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Felbamate Industry Trends Table 2. Felbamate Industry Drivers Table 3. Felbamate Industry Opportunities and Challenges Table 4. Felbamate Industry Restraints Table 5. Global Felbamate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Felbamate Revenue Share by Company (2021-2026) Table 7. Global Felbamate Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Felbamate Sales Volume Share by Company (2021-2026) Table 9. Global Felbamate Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Felbamate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Felbamate Key Company Manufacturing Base & Headquarters Table 12. Global Felbamate Company, Product Type & Application Table 13. Global Felbamate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Felbamate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Oral Solution Table 19. Global Felbamate Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Felbamate Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Felbamate Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Felbamate Sales Volume Share by Type (2021-2026) Table 23. Global Felbamate Sales Volume Share by Type (2027-2032) Table 24. Global Felbamate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Felbamate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Felbamate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Felbamate Sales Value Share by Type (2021-2026) Table 28. Global Felbamate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Refractory Lennox-Gastaut Syndrome Table 30. Significant Companies of Refractory Seizure Disorders Table 31. Significant Companies of Others Table 32. Global Felbamate Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Felbamate Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Felbamate Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Felbamate Sales Volume Share by Application (2021-2026) Table 36. Global Felbamate Sales Volume Share by Application (2027-2032) Table 37. Global Felbamate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Felbamate Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Felbamate Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Felbamate Sales Value Share by Application (2021-2026) Table 41. Global Felbamate Sales Value Share by Application (2027-2032) Table 42. Global Felbamate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Felbamate Sales by Region (2021-2026) & (K Units) Table 44. Global Felbamate Sales Market Share by Region (2021-2026) Table 45. Global Felbamate Sales by Region (2027-2032) & (K Units) Table 46. Global Felbamate Sales Market Share by Region (2027-2032) Table 47. Global Felbamate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Felbamate Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Felbamate Sales Value Share by Region (2021-2026) Table 50. Global Felbamate Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Felbamate Sales Value Share by Region (2027-2032) Table 52. Global Felbamate Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Felbamate Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Felbamate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Felbamate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Felbamate Sales by Country (2021-2026) & (K Units) Table 57. Global Felbamate Sales Market Share by Country (2021-2026) Table 58. Global Felbamate Sales by Country (2027-2032) & (K Units) Table 59. Global Felbamate Sales Market Share by Country (2027-2032) Table 60. Global Felbamate Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Felbamate Sales Value Market Share by Country (2021-2026) Table 62. Global Felbamate Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Felbamate Sales Value Market Share by Country (2027-2032) Table 64. Sun Pharma Company Information Table 65. Sun Pharma Business Overview Table 66. Sun Pharma Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sun Pharma Felbamate Product Portfolio Table 68. Sun Pharma Recent Development Table 69. Mylan Company Information Table 70. Mylan Business Overview Table 71. Mylan Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mylan Felbamate Product Portfolio Table 73. Mylan Recent Development Table 74. Schering Plough Company Information Table 75. Schering Plough Business Overview Table 76. Schering Plough Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Schering Plough Felbamate Product Portfolio Table 78. Schering Plough Recent Development Table 79. Merck Sharp and Dohme Company Information Table 80. Merck Sharp and Dohme Business Overview Table 81. Merck Sharp and Dohme Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Merck Sharp and Dohme Felbamate Product Portfolio Table 83. Merck Sharp and Dohme Recent Development Table 84. Corepharma Company Information Table 85. Corepharma Business Overview Table 86. Corepharma Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Corepharma Felbamate Product Portfolio Table 88. Corepharma Recent Development Table 89. Cadila Healthcare Company Information Table 90. Cadila Healthcare Business Overview Table 91. Cadila Healthcare Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Cadila Healthcare Felbamate Product Portfolio Table 93. Cadila Healthcare Recent Development Table 94. ANI Pharmaceuticals Company Information Table 95. ANI Pharmaceuticals Business Overview Table 96. ANI Pharmaceuticals Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. ANI Pharmaceuticals Felbamate Product Portfolio Table 98. ANI Pharmaceuticals Recent Development Table 99. Amneal Pharmaceuticals Company Information Table 100. Amneal Pharmaceuticals Business Overview Table 101. Amneal Pharmaceuticals Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Amneal Pharmaceuticals Felbamate Product Portfolio Table 103. Amneal Pharmaceuticals Recent Development Table 104. Alvogen Company Information Table 105. Alvogen Business Overview Table 106. Alvogen Felbamate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Alvogen Felbamate Product Portfolio Table 108. Alvogen Recent Development Table 109. Key Raw Materials Table 110. Raw Materials Key Suppliers Table 111. Felbamate Distributors List Table 112. Felbamate Customers List Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Felbamate Product Image Figure 2. Global Felbamate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felbamate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Felbamate Sales (2021-2032) & (K Units) Figure 5. Global Felbamate Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Felbamate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Oral Solution Image Figure 11. Global Felbamate Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Felbamate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Felbamate Sales Volume Share by Type (2021-2032) Figure 14. Global Felbamate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Felbamate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Felbamate Sales Value Share by Type (2021-2032) Figure 17. Refractory Lennox-Gastaut Syndrome Image Figure 18. Refractory Seizure Disorders Image Figure 19. Others Image Figure 20. Global Felbamate Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Felbamate Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Felbamate Sales Volume Share by Application (2021-2032) Figure 23. Global Felbamate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Felbamate Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Felbamate Sales Value Share by Application (2021-2032) Figure 26. Global Felbamate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Felbamate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Felbamate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Felbamate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Felbamate Sales Value (2021-2032) & (US$ Million) Figure 31. North America Felbamate Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Felbamate Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Felbamate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Felbamate Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Felbamate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Felbamate Sales Value (2021-2032) & (US$ Million) Figure 37. South America Felbamate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Felbamate Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Felbamate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Felbamate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Felbamate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Felbamate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Felbamate Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Felbamate Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Oral Solution
Applications
  • Refractory Lennox-Gastaut Syndrome
  • Refractory Seizure Disorders
  • Others
Companies covered
  • Sun Pharma
  • Mylan
  • Schering Plough
  • Merck Sharp and Dohme
  • Corepharma
  • Cadila Healthcare
  • ANI Pharmaceuticals
  • Amneal Pharmaceuticals
  • Alvogen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Felbamate Sales Value (2021-2032)
  4. 1.2.2 Global Felbamate Sales Volume (2021-2032)
  5. 1.2.3 Global Felbamate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Felbamate Market Dynamics
  1. 2.1 Felbamate Industry Trends
  2. 2.2 Felbamate Industry Drivers
  3. 2.3 Felbamate Industry Opportunities and Challenges
  4. 2.4 Felbamate Industry Restraints
3 Felbamate Market by Company
  1. 3.1 Global Felbamate Company Revenue Ranking in 2025
  2. 3.2 Global Felbamate Revenue by Company (2021-2026)
  3. 3.3 Global Felbamate Sales Volume by Company (2021-2026)
  4. 3.4 Global Felbamate Average Price by Company (2021-2026)
  5. 3.5 Global Felbamate Company Ranking (2024-2026)
  6. 3.6 Global Felbamate Company Manufacturing Base and Headquarters
  7. 3.7 Global Felbamate Company Product Type and Application
  8. 3.8 Global Felbamate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Felbamate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Felbamate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Felbamate Market by Type
  1. 4.1 Felbamate Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Oral Solution
  4. 4.2 Global Felbamate Sales Volume by Type
  5. 4.2.1 Global Felbamate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Felbamate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Felbamate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Felbamate Sales Value by Type
  9. 4.3.1 Global Felbamate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Felbamate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Felbamate Sales Value Share by Type (2021-2032)
5 Felbamate Market by Application
  1. 5.1 Felbamate Application Introduction
  2. 5.1.1 Refractory Lennox-Gastaut Syndrome
  3. 5.1.2 Refractory Seizure Disorders
  4. 5.1.3 Others
  5. 5.2 Global Felbamate Sales Volume by Application
  6. 5.2.1 Global Felbamate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felbamate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Felbamate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Felbamate Sales Value by Application
  10. 5.3.1 Global Felbamate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Felbamate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Felbamate Sales Value Share by Application (2021-2032)
6 Felbamate Regional Sales and Value Analysis
  1. 6.1 Global Felbamate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Felbamate Sales by Region (2021-2032)
  3. 6.2.1 Global Felbamate Sales by Region: 2021-2026
  4. 6.2.2 Global Felbamate Sales by Region (2027-2032)
  5. 6.3 Global Felbamate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Felbamate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Felbamate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Felbamate Sales Value by Region (2027-2032)
  9. 6.5 Global Felbamate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Felbamate Sales Value (2021-2032)
  12. 6.6.2 North America Felbamate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Felbamate Sales Value (2021-2032)
  15. 6.7.2 Europe Felbamate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Felbamate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Felbamate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Felbamate Sales Value (2021-2032)
  21. 6.9.2 South America Felbamate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Felbamate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Felbamate Sales Value Share by Country, 2025 VS 2032
7 Felbamate Country-level Sales and Value Analysis
  1. 7.1 Global Felbamate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Felbamate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Felbamate Sales by Country (2021-2032)
  4. 7.3.1 Global Felbamate Sales by Country (2021-2026)
  5. 7.3.2 Global Felbamate Sales by Country (2027-2032)
  6. 7.4 Global Felbamate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Felbamate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Felbamate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Felbamate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Felbamate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Felbamate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Felbamate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Felbamate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Felbamate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Felbamate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Felbamate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Felbamate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Felbamate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Felbamate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Felbamate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Felbamate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Felbamate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Felbamate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Felbamate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Felbamate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Felbamate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Felbamate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Felbamate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Felbamate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Felbamate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Felbamate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Felbamate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Felbamate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Felbamate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Felbamate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Felbamate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Felbamate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Felbamate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Felbamate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Felbamate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Felbamate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Felbamate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Felbamate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Felbamate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Felbamate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Felbamate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Felbamate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Felbamate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Felbamate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Felbamate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Felbamate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Felbamate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Felbamate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Felbamate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Felbamate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Felbamate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Felbamate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Felbamate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Felbamate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Felbamate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Felbamate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Felbamate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Felbamate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Felbamate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Felbamate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Felbamate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Felbamate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Felbamate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Felbamate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Felbamate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Felbamate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Felbamate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Felbamate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Felbamate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Felbamate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Felbamate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Felbamate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Felbamate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Felbamate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Felbamate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Felbamate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Felbamate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Felbamate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Felbamate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Felbamate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Felbamate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Felbamate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Felbamate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Felbamate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Felbamate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Felbamate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Felbamate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharma
  2. 8.1.1 Sun Pharma Company Information
  3. 8.1.2 Sun Pharma Business Overview
  4. 8.1.3 Sun Pharma Felbamate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharma Felbamate Product Portfolio
  6. 8.1.5 Sun Pharma Recent Developments
  7. 8.2 Mylan
  8. 8.2.1 Mylan Company Information
  9. 8.2.2 Mylan Business Overview
  10. 8.2.3 Mylan Felbamate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Mylan Felbamate Product Portfolio
  12. 8.2.5 Mylan Recent Developments
  13. 8.3 Schering Plough
  14. 8.3.1 Schering Plough Company Information
  15. 8.3.2 Schering Plough Business Overview
  16. 8.3.3 Schering Plough Felbamate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Schering Plough Felbamate Product Portfolio
  18. 8.3.5 Schering Plough Recent Developments
  19. 8.4 Merck Sharp and Dohme
  20. 8.4.1 Merck Sharp and Dohme Company Information
  21. 8.4.2 Merck Sharp and Dohme Business Overview
  22. 8.4.3 Merck Sharp and Dohme Felbamate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Sharp and Dohme Felbamate Product Portfolio
  24. 8.4.5 Merck Sharp and Dohme Recent Developments
  25. 8.5 Corepharma
  26. 8.5.1 Corepharma Company Information
  27. 8.5.2 Corepharma Business Overview
  28. 8.5.3 Corepharma Felbamate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Corepharma Felbamate Product Portfolio
  30. 8.5.5 Corepharma Recent Developments
  31. 8.6 Cadila Healthcare
  32. 8.6.1 Cadila Healthcare Company Information
  33. 8.6.2 Cadila Healthcare Business Overview
  34. 8.6.3 Cadila Healthcare Felbamate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cadila Healthcare Felbamate Product Portfolio
  36. 8.6.5 Cadila Healthcare Recent Developments
  37. 8.7 ANI Pharmaceuticals
  38. 8.7.1 ANI Pharmaceuticals Company Information
  39. 8.7.2 ANI Pharmaceuticals Business Overview
  40. 8.7.3 ANI Pharmaceuticals Felbamate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ANI Pharmaceuticals Felbamate Product Portfolio
  42. 8.7.5 ANI Pharmaceuticals Recent Developments
  43. 8.8 Amneal Pharmaceuticals
  44. 8.8.1 Amneal Pharmaceuticals Company Information
  45. 8.8.2 Amneal Pharmaceuticals Business Overview
  46. 8.8.3 Amneal Pharmaceuticals Felbamate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Amneal Pharmaceuticals Felbamate Product Portfolio
  48. 8.8.5 Amneal Pharmaceuticals Recent Developments
  49. 8.9 Alvogen
  50. 8.9.1 Alvogen Company Information
  51. 8.9.2 Alvogen Business Overview
  52. 8.9.3 Alvogen Felbamate Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Alvogen Felbamate Product Portfolio
  54. 8.9.5 Alvogen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Felbamate Value Chain Analysis
  2. 9.1.1 Felbamate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Felbamate Sales Mode & Process
  6. 9.2 Felbamate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Felbamate Distributors
  9. 9.2.3 Felbamate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst